5-HT2C receptor modulation and the treatment of obesity

被引：36
|
作者：
Bickerdike, MJ [1 ]
Vickers, SP [1 ]
Dourish, CT [1 ]
机构：
[1] Cerebrus PLC, Wokingham RG41 5UA, England
来源：
DIABETES OBESITY & METABOLISM | 1999年 / 1卷 / 04期
关键词：
D O I：
10.1046/j.1463-1326.1999.00037.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：207 / 214
页数：8
相关论文
共 50 条
  • [1] A 5-HT2C receptor agonist for the treatment of obesity?
    Van Baak, M
    Lentjes, M
    Mujakovic, S
    Slaap, B
    Saris, W
    OBESITY RESEARCH, 2003, 11 : A110 - A111
  • [2] Serotonin 5-HT2C receptor agonists:: For the treatment of obesity
    Miller, KJ
    MOLECULAR INTERVENTIONS, 2005, 5 (05) : 282 - 291
  • [3] 5-HT2C receptor agonists as potential drugs for the treatment of obesity
    Bickerdike, MJ
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (08) : 885 - 897
  • [4] 5-HT2C receptor ligands in the treatment of obesity and type 2 diabetes
    Heisler, L. K.
    Lam, D. D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S182 - S182
  • [5] Discovery of Lorcaserin: A selective 5-HT2C receptor agonist for the treatment of obesity
    Smith, Brian M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [6] Indazoles as selective 5-HT2C receptor agonists for the treatment of obesity.
    Dawson, CE
    Adams, DR
    Bentley, JM
    Benwell, K
    Bickerdike, MJ
    Cliffe, IA
    Duncton, MAJ
    Hamlyn, RJ
    Kennett, GA
    Knight, T
    Malcolm, C
    Misra, A
    Roffey, JR
    Vickers, S
    Dourish, CT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67
  • [7] Novel pyrimidoazepine analogs as serotonin 5-HT2A and 5-HT2C receptor ligands for the treatment of obesity
    Yang, Ha Yun
    Tae, Jinsung
    Seo, Yong Wan
    Kim, Yoon Jung
    Im, Hye Yeon
    Choi, Gil Don
    Cho, Heeyeong
    Park, Woo-Kyu
    Kwon, Oh Seung
    Cho, Yong Seo
    Ko, Minkyung
    Jang, HyunSeo
    Lee, Jaeick
    Choi, Kihang
    Kim, Chan-Hwa
    Lee, Jiyoun
    Pae, Ae Nim
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 63 : 558 - 569
  • [8] 5-HT2C receptor agonists for the treatment of obesity.: Biological and chemical adventures
    Adams, D
    Bénardeau, A
    Bickerdike, MJ
    Bentley, JM
    Bissantz, C
    Bourson, A
    Cliffe, IA
    Hebeisen, P
    Kennett, GA
    Knight, AR
    Malcolm, CS
    Mizrahi, J
    Plancher, JM
    Richter, H
    Röver, S
    Taylor, S
    Vickers, SP
    CHIMIA, 2004, 58 (09) : 613 - 620
  • [9] Discovery and development of selective 5-HT2C receptor agonists for obesity
    Dourish, C. T.
    Adams, D. R.
    Bentley, J.
    Benwell, K.
    Bickerdike, M. J.
    Harrison, K.
    Kennett, G. A.
    Knight, A. R.
    Lightowler, S. L.
    Malcolm, C.
    Misra, A.
    Vickers, S. P.
    Cliffe, I. A.
    Coassolo, P.
    Frei, B.
    Mizrahi, J.
    Stalder, H.
    Stephan-Guldner, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 127 - 127
  • [10] A Positive Allosteric Modulator of the Serotonin 5-HT2c Receptor for Obesity
    Garcia-Carceles, Javier
    Decara, Juan M.
    Vazquez-Villa, Henar
    Rodriguez, Ramon
    Codesido, Eva
    Cruces, Jacobo
    Brea, Jose
    Loza, Maria I.
    Alen, Francisco
    Botta, Joaquin
    McCormick, Peter J.
    Ballesteros, Juan A.
    Benhamu, Bellinda
    Rodriguez de Fonseca, Fernando
    Lopez-Rodriguez, Maria L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9575 - 9584
12345